Formulation and Characterization of Losartan Loaded Chitosan Microspheres: Effect of Crosslinking Agents
Authors:
- 21 December 2020
- journal article
- research article
- Published by Georg Thieme Verlag KG in Drug Research
- Vol. 71 (04) , 204-212
Abstract
Objective The present investigation entailed determination of effect of diverse cross-linking agents on Losartan Potassium loaded chitosan microspheres. The emulsion cross-linking method was employed to formulate the microspheres with an endeavour to achieve maximum sustained effect. Methods The FTIR studies revealed absence of any interaction between Losartan and chitosan. The emulsion cross linking method was accomplished in three steps encompassing formation of an aqueous and oily phase, emulsification and cross-linking. A total of eighteen Losartan formulations were developed using six different cross-linkers at three varying level were screened for optimum parameters. The in vitro drug release parameters of optimum formulations (LC3, LE3, LF3, LG3, LS3 and LV3) containing citric acid, epichlorohydrin, formaldehyde, glutaraldehyde, suphuric acid and vanillin as cross-linkers were assessed to determine the sustained effect. Results The values of evaluated parameters including percent yield (94.67%), average particle size (51.19 µm), drug content (44.38 mg) and entrapment efficiency (88.77%) connoted LG3 as the best formulation. Additionally, the values of relative measure of skewness (β1=0.01 and γ1=0.10) and platykurtic (β2=1.26) size distribution were least for LG3 with spherical shape and smooth surface as revealed by SEM studies. Conclusion The outcome of in vitro release and other characterizations of microspheres explicitly revealed glutaraldehyde as the best cross-linker amongst the cross-linkers used herewith. The maximum sustained effect (lasting over a period of 24 h) accompanied with higher MDT and t50% with lower%DE and Q14h values thus corroborated the objective of attaining sustained release of Losartan. Received: 27 July 2020 Accepted: 23 November 2020 Publication Date: 21 December 2020 (online) © 2020. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyKeywords
This publication has 23 references indexed in Scilit:
- Development of Nasal Mucoadhesive Microspheres of Granisetron: A Potential DrugDrug Research, 2020
- Antibacterial effects and ibuprofen release potential using chitosan microspheres loaded with silver nanoparticlesCarbohydrate Research, 2020
- Preparation and characterization of porous chitosan microspheres and adsorption performance for hexavalent chromiumInternational Journal of Biological Macromolecules, 2019
- RETRACTED ARTICLE: Modification of Novel Chitosan-Starch Cross-Linked Derivatives Polymers: Synthesis and CharacterizationJournal of Polymers and the Environment, 2019
- Preparation and Properties of 5-Fluorouracil-Loaded Chitosan Microspheres for the Intranasal AdministrationDrug Research, 2018
- Preparation and characterization of poly(maleic acid)-grafted cross-linked chitosan microspheres for Cd(II) adsorptionCarbohydrate Polymers, 2017
- Losartan, a selective antagonist of AT1 receptor, attenuates seawater inhalation induced lung injury via modulating JAK2/STATs and apoptosis in ratPulmonary Pharmacology & Therapeutics, 2017
- Preparation and characterization of vanillin-crosslinked chitosan therapeutic bioactive microcarriersInternational Journal of Biological Macromolecules, 2015
- In Vitro and In Vivo Studies on Chitosan Beads of Losartan Duolite AP143 Complex, Optimized by Using Statistical Experimental DesignAAPS PharmSciTech, 2009
- Effect of crosslinking agents on chitosan microspheres in controlled release of diclofenac sodiumPolímeros, 2005